Dec. 10, 2019: Cancer patients can begin from today potential access to the UK’s first MRIdian machine, a new radiotherapy treatment to reduce treatment time and cause fewer side effects.
This technology combines magnetic resonance imaging (MRI) techniques with high precision radiotherapy beams that allow clinicians to adapt treatment to take account of tumour movement in real time, which reduces the amount of healthy tissue hit by radiotherapy, thereby lowering the risk of side effects.
Although, machine enables higher doses to certain tumours than would be possible using conventional radiotherapy treatment time can be shortened.
the MRIdian early stage prostate cancer patients typically require five treatments while with conventional radiotherapy, it require at least 20 treatments. https://www.icr.ac.uk/news-archive/first-patient-in-the-uk-receives-pioneering-new-form-of-radiotherapy
